https://gentaur.com/products/25204666-anti-human-cxadr-med-bio-labs-patent-anti-cxadr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204667-anti-human-cxadr-med-bio-labs-patent-anti-cxadr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204668-anti-human-cxadr-med-bio-labs-patent-anti-cxadr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204669-anti-human-lewis-y-mb-311-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204670-anti-human-lewis-y-mb-311-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204671-anti-human-lewis-y-mb-311-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204672-anti-human-il-1r1-cd121a-amg-108-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204673-anti-human-il-1r1-cd121a-amg-108-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204674-anti-human-il-1r1-cd121a-amg-108-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204675-anti-human-il-33-etokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204676-anti-human-il-33-etokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204677-anti-human-il-33-etokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204678-anti-human-il-13-anrukinzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204679-anti-human-il-13-anrukinzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204680-anti-human-il-13-anrukinzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204681-anti-human-mer-mertk-rgx-019-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204682-anti-human-mer-mertk-rgx-019-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204683-anti-human-mer-mertk-rgx-019-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204684-anti-human-erbb3-her3-seribantumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204685-anti-human-erbb3-her3-seribantumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204686-anti-human-erbb3-her3-seribantumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204687-anti-human-gpnmb-glembatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204688-anti-human-gpnmb-glembatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204689-anti-human-gpnmb-glembatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204690-anti-human-il-13ra2-cd213a2-wake-forest-u-patent-anti-il-13ra2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204691-anti-human-il-13ra2-cd213a2-wake-forest-u-patent-anti-il-13ra2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204692-anti-human-il-13ra2-cd213a2-wake-forest-u-patent-anti-il-13ra2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204693-anti-human-loxl2-simtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204694-anti-human-loxl2-simtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204695-anti-human-loxl2-simtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204696-anti-human-il-23a-tildrakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204697-anti-human-il-23a-tildrakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204698-anti-human-il-23a-tildrakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204699-anti-human-sirpa-cd172a-hospital-for-sick-children-patent-anti-sirpa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204700-anti-human-sirpa-cd172a-hospital-for-sick-children-patent-anti-sirpa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204701-anti-human-sirpa-cd172a-hospital-for-sick-children-patent-anti-sirpa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204702-anti-human-tnfsf4-ox40l-cd252-oxelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204703-anti-human-tnfsf4-ox40l-cd252-oxelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204704-anti-human-tnfsf4-ox40l-cd252-oxelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204705-anti-human-pdgfrb-cd140b-rinucumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204706-anti-human-pdgfrb-cd140b-rinucumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204707-anti-human-pdgfrb-cd140b-rinucumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204708-anti-human-ifna1-sifalimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204709-anti-human-ifna1-sifalimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204710-anti-human-ifna1-sifalimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204711-anti-human-lepr-cd295-mibavademab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204712-anti-human-lepr-cd295-mibavademab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204713-anti-human-lepr-cd295-mibavademab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204714-anti-human-mif-imalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204715-anti-human-mif-imalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204716-anti-human-mif-imalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204717-anti-human-tnfrsf5-cd40-dacetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204718-anti-human-tnfrsf5-cd40-dacetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204719-anti-human-tnfrsf5-cd40-dacetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204720-anti-human-il-5-mepolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204721-anti-human-il-5-mepolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204722-anti-human-il-5-mepolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204723-anti-human-cxcl8-il-8-humax-il8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204724-anti-human-cxcl8-il-8-humax-il8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204725-anti-human-cxcl8-il-8-humax-il8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204726-anti-human-masp2-narsoplimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204727-anti-human-masp2-narsoplimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204728-anti-human-masp2-narsoplimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204729-anti-human-gdf8-myostatin-trevogrumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204730-anti-human-gdf8-myostatin-trevogrumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204731-anti-human-gdf8-myostatin-trevogrumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204732-anti-human-rtn4-nogo-ozanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204733-anti-human-rtn4-nogo-ozanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204734-anti-human-rtn4-nogo-ozanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204735-anti-human-muc1-clivatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204736-anti-human-muc1-clivatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204737-anti-human-muc1-clivatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204738-anti-human-il-9-enokizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204739-anti-human-il-9-enokizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204740-anti-human-il-9-enokizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204741-anti-human-il-1rl2-il-36r-imsidolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204742-anti-human-il-1rl2-il-36r-imsidolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204743-anti-human-il-1rl2-il-36r-imsidolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204744-anti-human-pcsk9-alirocumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204745-anti-human-pcsk9-alirocumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204746-anti-human-pcsk9-alirocumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204747-anti-human-magea3-ct-atlantic-patent-anti-mage-a3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204748-anti-human-magea3-ct-atlantic-patent-anti-mage-a3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204749-anti-human-magea3-ct-atlantic-patent-anti-mage-a3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204750-anti-human-siglec-4a-mag-refanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204751-anti-human-siglec-4a-mag-refanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204752-anti-human-siglec-4a-mag-refanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204753-anti-human-gcgr-volagidemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204754-anti-human-gcgr-volagidemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204755-anti-human-gcgr-volagidemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204756-anti-human-gpr49-lgr5-bnc101-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204757-anti-human-gpr49-lgr5-bnc101-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204758-anti-human-gpr49-lgr5-bnc101-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204759-anti-human-pglyrp1-pgrp-s-novo-nordisk-patent-anti-pglyrp1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204760-anti-human-pglyrp1-pgrp-s-novo-nordisk-patent-anti-pglyrp1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204761-anti-human-pglyrp1-pgrp-s-novo-nordisk-patent-anti-pglyrp1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204762-anti-human-pvrig-gsk4381562-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204763-anti-human-pvrig-gsk4381562-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204764-anti-human-pvrig-gsk4381562-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204765-anti-human-igf-1-xentuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204766-anti-human-igf-1-xentuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204767-anti-human-igf-1-xentuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204768-anti-human-pvrig-com701-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204769-anti-human-pvrig-com701-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204770-anti-human-pvrig-com701-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204771-anti-human-ngf-bngf-fulranumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204772-anti-human-ngf-bngf-fulranumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204773-anti-human-ngf-bngf-fulranumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204774-anti-human-mu5ac-ensituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204775-anti-human-mu5ac-ensituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204776-anti-human-mu5ac-ensituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204777-anti-human-sost-sclerostin-setrusumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204778-anti-human-sost-sclerostin-setrusumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204779-anti-human-sost-sclerostin-setrusumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204780-anti-human-sirpg-cd172g-kwar23-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204781-anti-human-sirpg-cd172g-kwar23-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204782-anti-human-sirpg-cd172g-kwar23-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204783-anti-human-il-4ra-cd124-dupilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204784-anti-human-il-4ra-cd124-dupilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204785-anti-human-il-4ra-cd124-dupilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204786-anti-human-rspo1-oncomed-patent-anti-rspo1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204787-anti-human-rspo1-oncomed-patent-anti-rspo1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204788-anti-human-rspo1-oncomed-patent-anti-rspo1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204789-anti-human-il-7ra-cd127-lusvertikimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204790-anti-human-il-7ra-cd127-lusvertikimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204791-anti-human-il-7ra-cd127-lusvertikimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204792-anti-human-il-2ra-cd25-basiliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204793-anti-human-il-2ra-cd25-basiliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204794-anti-human-il-2ra-cd25-basiliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204795-anti-human-lag3-cd223-relatlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204796-anti-human-lag3-cd223-relatlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204797-anti-human-lag3-cd223-relatlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204798-anti-human-ager-rage-xt-m4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204799-anti-human-ager-rage-xt-m4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204800-anti-human-ager-rage-xt-m4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204801-anti-human-tnfsf11-rankl-cd254-denosumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204802-anti-human-tnfsf11-rankl-cd254-denosumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204803-anti-human-tnfsf11-rankl-cd254-denosumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204804-anti-human-syndecan-1-cd138-indatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204805-anti-human-syndecan-1-cd138-indatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204806-anti-human-syndecan-1-cd138-indatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204807-anti-human-tau-gosuranemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204808-anti-human-tau-gosuranemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204809-anti-human-tau-gosuranemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204810-anti-human-igf1r-cd221-teprotumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204811-anti-human-igf1r-cd221-teprotumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204812-anti-human-igf1r-cd221-teprotumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204813-anti-human-pdgfc-vegfe-thrombogenics-patent-anti-pdgf-c-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204814-anti-human-pdgfc-vegfe-thrombogenics-patent-anti-pdgf-c-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204815-anti-human-pdgfc-vegfe-thrombogenics-patent-anti-pdgf-c-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204816-anti-human-pdgfra-cd140a-olaratumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204817-anti-human-pdgfra-cd140a-olaratumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204818-anti-human-pdgfra-cd140a-olaratumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204819-anti-human-mspr-ron-cd136-narnatumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204820-anti-human-mspr-ron-cd136-narnatumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204821-anti-human-mspr-ron-cd136-narnatumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204822-anti-human-lap-brigham-and-womens-anti-lap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204823-anti-human-lap-brigham-and-womens-anti-lap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204824-anti-human-lap-brigham-and-womens-anti-lap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204825-anti-human-il-20ra-cheng-kung-u-patent-anti-il-20r1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204826-anti-human-il-20ra-cheng-kung-u-patent-anti-il-20r1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204827-anti-human-il-20ra-cheng-kung-u-patent-anti-il-20r1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204828-anti-human-tnfrsf12a-tweakr-cd266-enavatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204829-anti-human-tnfrsf12a-tweakr-cd266-enavatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204830-anti-human-tnfrsf12a-tweakr-cd266-enavatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204831-anti-human-mesothelin-anetumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204832-anti-human-mesothelin-anetumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204833-anti-human-mesothelin-anetumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204834-anti-human-tgfb1-m7824-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204835-anti-human-tgfb1-m7824-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204836-anti-human-tgfb1-m7824-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204837-anti-human-cdh6-k-cadherin-ds-6000a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204838-anti-human-cdh6-k-cadherin-ds-6000a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204839-anti-human-cdh6-k-cadherin-ds-6000a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204840-anti-human-trka-ntrk1-gbr-900-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204841-anti-human-trka-ntrk1-gbr-900-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204842-anti-human-trka-ntrk1-gbr-900-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204843-anti-human-tlr2-cd282-tomaralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204844-anti-human-tlr2-cd282-tomaralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204845-anti-human-tlr2-cd282-tomaralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204846-anti-human-slc1a5-asct2-idactamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204847-anti-human-slc1a5-asct2-idactamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204848-anti-human-slc1a5-asct2-idactamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204849-anti-human-il-22-fezakinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204850-anti-human-il-22-fezakinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204851-anti-human-il-22-fezakinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204852-anti-human-sema4d-cd100-pepinemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204853-anti-human-sema4d-cd100-pepinemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204854-anti-human-sema4d-cd100-pepinemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204855-anti-human-il-2ra-cd25-daclizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204856-anti-human-il-2ra-cd25-daclizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204857-anti-human-il-2ra-cd25-daclizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204858-anti-human-notch1-brontictuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204859-anti-human-notch1-brontictuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204860-anti-human-notch1-brontictuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204861-anti-human-robo1-asclepius-technology-patent-anti-robo1-car-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204862-anti-human-robo1-asclepius-technology-patent-anti-robo1-car-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204863-anti-human-robo1-asclepius-technology-patent-anti-robo1-car-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204864-anti-human-ngf-bngf-tanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204865-anti-human-ngf-bngf-tanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204866-anti-human-ngf-bngf-tanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204867-anti-human-calcrl-cgrpr-erenumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204868-anti-human-calcrl-cgrpr-erenumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204869-anti-human-calcrl-cgrpr-erenumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204870-anti-human-aoc3-vap1-timolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204871-anti-human-aoc3-vap1-timolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204872-anti-human-aoc3-vap1-timolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204873-anti-human-nrp1-vegf165r-cd304-vesencumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204874-anti-human-nrp1-vegf165r-cd304-vesencumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204875-anti-human-nrp1-vegf165r-cd304-vesencumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204876-anti-human-muc16-oregovomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204877-anti-human-muc16-oregovomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204878-anti-human-muc16-oregovomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204879-anti-human-btn1a1-ctx-2026-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204880-anti-human-btn1a1-ctx-2026-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204881-anti-human-btn1a1-ctx-2026-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204882-anti-human-inhba-activin-a-garetosmab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204883-anti-human-inhba-activin-a-garetosmab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204884-anti-human-inhba-activin-a-garetosmab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204885-anti-human-cd6-itolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204886-anti-human-cd6-itolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204887-anti-human-cd6-itolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204888-anti-human-cd14-atibuclimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204889-anti-human-cd14-atibuclimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204890-anti-human-cd14-atibuclimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204891-anti-human-phosphorylcholine-ath3g10-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204892-anti-human-phosphorylcholine-ath3g10-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204893-anti-human-phosphorylcholine-ath3g10-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204894-anti-human-tnfrsf4-ox40-cd134-tavolixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204895-anti-human-tnfrsf4-ox40-cd134-tavolixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204896-anti-human-tnfrsf4-ox40-cd134-tavolixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204897-anti-human-il-5ra-cd125-benralizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204898-anti-human-il-5ra-cd125-benralizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204899-anti-human-il-5ra-cd125-benralizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204900-anti-human-complement-c2-argx-117-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204901-anti-human-complement-c2-argx-117-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204902-anti-human-complement-c2-argx-117-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204903-anti-human-madcam1-ontamalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204904-anti-human-madcam1-ontamalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204905-anti-human-madcam1-ontamalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204906-anti-human-hgf-sf-rilotumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204907-anti-human-hgf-sf-rilotumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204908-anti-human-hgf-sf-rilotumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204909-anti-human-ildr2-bapotulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204910-anti-human-ildr2-bapotulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204911-anti-human-ildr2-bapotulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204912-anti-human-tnfrsf13c-baffr-cd268-ianalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204913-anti-human-tnfrsf13c-baffr-cd268-ianalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204914-anti-human-tnfrsf13c-baffr-cd268-ianalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204915-anti-human-tgfb1-srk181-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204916-anti-human-tgfb1-srk181-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204917-anti-human-tgfb1-srk181-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204918-anti-human-cd48-regeneron-patent-anti-cd48-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204919-anti-human-cd48-regeneron-patent-anti-cd48-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204920-anti-human-cd48-regeneron-patent-anti-cd48-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204921-anti-human-rspo3-rosmantuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204922-anti-human-rspo3-rosmantuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204923-anti-human-rspo3-rosmantuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204924-anti-human-endoglin-cd105-carotuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204925-anti-human-endoglin-cd105-carotuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204926-anti-human-endoglin-cd105-carotuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204927-anti-human-amhr2-murlentamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204928-anti-human-amhr2-murlentamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204929-anti-human-amhr2-murlentamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204930-anti-human-prame-eureka-patent-anti-prame-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204931-anti-human-prame-eureka-patent-anti-prame-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204932-anti-human-prame-eureka-patent-anti-prame-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204933-anti-human-fzd10-tabituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204934-anti-human-fzd10-tabituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204935-anti-human-fzd10-tabituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204936-anti-human-csf2rb-cd131-csl311-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204937-anti-human-csf2rb-cd131-csl311-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204938-anti-human-csf2rb-cd131-csl311-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204939-anti-human-tnfrsf10a-trailr1-cd261-mapatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204940-anti-human-tnfrsf10a-trailr1-cd261-mapatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204941-anti-human-tnfrsf10a-trailr1-cd261-mapatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204942-anti-human-gpc1-glypican-1-minomic-patent-anti-glypican-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204943-anti-human-gpc1-glypican-1-minomic-patent-anti-glypican-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204944-anti-human-gpc1-glypican-1-minomic-patent-anti-glypican-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204945-anti-human-tf-factor-iii-tissue-factor-cd142-tisotumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204946-anti-human-tf-factor-iii-tissue-factor-cd142-tisotumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204947-anti-human-tf-factor-iii-tissue-factor-cd142-tisotumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204948-anti-human-gfral-ngm120-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204949-anti-human-gfral-ngm120-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204950-anti-human-gfral-ngm120-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204951-anti-human-melanotransferrin-cd228-sc-005-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204952-anti-human-melanotransferrin-cd228-sc-005-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204953-anti-human-melanotransferrin-cd228-sc-005-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204954-anti-human-c1q-anx005-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204955-anti-human-c1q-anx005-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204956-anti-human-c1q-anx005-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204957-anti-human-integrin-avb6-stx-100-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204958-anti-human-integrin-avb6-stx-100-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204959-anti-human-integrin-avb6-stx-100-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204960-anti-human-acvr2b-acceleron-patent-anti-actriib-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204961-anti-human-acvr2b-acceleron-patent-anti-actriib-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204962-anti-human-acvr2b-acceleron-patent-anti-actriib-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204963-anti-human-pla2g1b-diaccurate-patent-anti-spla2-gib-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204964-anti-human-pla2g1b-diaccurate-patent-anti-spla2-gib-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204965-anti-human-pla2g1b-diaccurate-patent-anti-spla2-gib-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204966-anti-human-fucosyl-gm1-bms-986012-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204967-anti-human-fucosyl-gm1-bms-986012-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204968-anti-human-fucosyl-gm1-bms-986012-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204969-anti-human-sost-sclerostin-romosozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204970-anti-human-sost-sclerostin-romosozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204971-anti-human-sost-sclerostin-romosozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204972-anti-human-vegfb-csl346-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204973-anti-human-vegfb-csl346-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204974-anti-human-vegfb-csl346-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204975-anti-human-tau-semorinemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204976-anti-human-tau-semorinemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204977-anti-human-tau-semorinemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204978-anti-human-csf3-g-csf-csl324-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204979-anti-human-csf3-g-csf-csl324-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204980-anti-human-csf3-g-csf-csl324-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204981-anti-human-tim-3-havcr2-cd366-sabatolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204982-anti-human-tim-3-havcr2-cd366-sabatolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204983-anti-human-tim-3-havcr2-cd366-sabatolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204984-anti-human-cd59-mellitus-patent-anti-cd59-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204985-anti-human-cd59-mellitus-patent-anti-cd59-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204986-anti-human-cd59-mellitus-patent-anti-cd59-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204987-anti-human-cb1-cnr1-gfb-024-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204988-anti-human-cb1-cnr1-gfb-024-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204989-anti-human-cb1-cnr1-gfb-024-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204990-anti-human-vwf-inserm-patent-anti-vwf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204991-anti-human-vwf-inserm-patent-anti-vwf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204992-anti-human-vwf-inserm-patent-anti-vwf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204993-anti-human-clusterin-ab-16b5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204994-anti-human-clusterin-ab-16b5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204995-anti-human-clusterin-ab-16b5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204996-anti-human-complement-c3-ngm621-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204997-anti-human-complement-c3-ngm621-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204998-anti-human-complement-c3-ngm621-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204999-anti-human-tnfrsf10b-trailr2-cd262-drozitumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205000-anti-human-tnfrsf10b-trailr2-cd262-drozitumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205001-anti-human-tnfrsf10b-trailr2-cd262-drozitumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205002-anti-human-complement-factor-p-properdin-novelmed-patent-anti-properdin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205003-anti-human-complement-factor-p-properdin-novelmed-patent-anti-properdin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205004-anti-human-complement-factor-p-properdin-novelmed-patent-anti-properdin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205005-anti-human-integrin-b1-itgb1-cd29-os2966-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205006-anti-human-integrin-b1-itgb1-cd29-os2966-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205007-anti-human-integrin-b1-itgb1-cd29-os2966-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205008-anti-human-orai1-amgen-patent-anti-orai1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205009-anti-human-orai1-amgen-patent-anti-orai1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205010-anti-human-orai1-amgen-patent-anti-orai1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205011-anti-human-tmeff1-tomoregulin-1-bluefin-patent-anti-tmeff1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205012-anti-human-tmeff1-tomoregulin-1-bluefin-patent-anti-tmeff1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205013-anti-human-tmeff1-tomoregulin-1-bluefin-patent-anti-tmeff1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205014-anti-human-tpsab1-genentech-patent-anti-tryptase-beta-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205015-anti-human-tpsab1-genentech-patent-anti-tryptase-beta-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205016-anti-human-tpsab1-genentech-patent-anti-tryptase-beta-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205017-anti-human-gucy2c-indusatumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205018-anti-human-gucy2c-indusatumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205019-anti-human-gucy2c-indusatumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205020-anti-human-adrenomedullin-enibarcimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205021-anti-human-adrenomedullin-enibarcimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205022-anti-human-adrenomedullin-enibarcimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205023-anti-human-gp6-glycoprotein-6-glenzocimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205024-anti-human-gp6-glycoprotein-6-glenzocimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205025-anti-human-gp6-glycoprotein-6-glenzocimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205026-anti-human-angptl8-regeneron-patent-anti-angptl8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205027-anti-human-angptl8-regeneron-patent-anti-angptl8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205028-anti-human-angptl8-regeneron-patent-anti-angptl8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205029-anti-human-trop2-sacituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205030-anti-human-trop2-sacituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205031-anti-human-trop2-sacituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205032-anti-human-klk5-kallikrein-5-genentech-patent-anti-klk5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205033-anti-human-klk5-kallikrein-5-genentech-patent-anti-klk5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205034-anti-human-klk5-kallikrein-5-genentech-patent-anti-klk5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205035-anti-human-tshr-k1-70-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205036-anti-human-tshr-k1-70-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205037-anti-human-tshr-k1-70-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205038-anti-human-amyloid-alpha-birtamimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205039-anti-human-amyloid-alpha-birtamimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205040-anti-human-amyloid-alpha-birtamimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205041-anti-human-cd44v6-bivatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205042-anti-human-cd44v6-bivatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205043-anti-human-cd44v6-bivatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205044-anti-human-pacap38-lilly-patent-anti-pacap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205045-anti-human-pacap38-lilly-patent-anti-pacap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205046-anti-human-pacap38-lilly-patent-anti-pacap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205047-anti-human-mspr-ron-cd136-aveo-anti-ron-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205048-anti-human-mspr-ron-cd136-aveo-anti-ron-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205049-anti-human-mspr-ron-cd136-aveo-anti-ron-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205050-anti-human-cd38-isatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205051-anti-human-cd38-isatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205052-anti-human-cd38-isatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205053-anti-human-gpr20-ds-6157-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205054-anti-human-gpr20-ds-6157-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205055-anti-human-gpr20-ds-6157-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205056-anti-human-cd7-grisnilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205057-anti-human-cd7-grisnilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205058-anti-human-cd7-grisnilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205059-anti-human-ifnar1-anifrolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205060-anti-human-ifnar1-anifrolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205061-anti-human-ifnar1-anifrolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205062-anti-human-cd74-milatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205063-anti-human-cd74-milatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205064-anti-human-cd74-milatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205065-anti-human-napi2b-slc34a2-lifastuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205066-anti-human-napi2b-slc34a2-lifastuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205067-anti-human-napi2b-slc34a2-lifastuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205068-anti-human-cd38-mezagitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205069-anti-human-cd38-mezagitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205070-anti-human-cd38-mezagitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205071-anti-human-amyloid-beta-dlx212-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205072-anti-human-amyloid-beta-dlx212-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205073-anti-human-amyloid-beta-dlx212-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205074-anti-human-stab1-bexmarilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205075-anti-human-stab1-bexmarilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205076-anti-human-stab1-bexmarilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205077-anti-human-cd4-trx1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205078-anti-human-cd4-trx1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205079-anti-human-cd4-trx1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205080-anti-human-cd4-tregalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205081-anti-human-cd4-tregalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205082-anti-human-cd4-tregalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205083-anti-human-cd4-ibalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205084-anti-human-cd4-ibalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205085-anti-human-cd4-ibalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205086-anti-human-il-22ra-argx-112-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205087-anti-human-il-22ra-argx-112-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205088-anti-human-il-22ra-argx-112-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205089-anti-human-cd28l-cd80-galiximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205090-anti-human-cd28l-cd80-galiximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205091-anti-human-cd28l-cd80-galiximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205092-anti-human-gpr44-ptgdr2-cd294-khk-patent-anti-crth2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205093-anti-human-gpr44-ptgdr2-cd294-khk-patent-anti-crth2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205094-anti-human-gpr44-ptgdr2-cd294-khk-patent-anti-crth2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205095-anti-human-fgf23-burosumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205096-anti-human-fgf23-burosumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205097-anti-human-fgf23-burosumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205098-anti-human-par2-par650097-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205099-anti-human-par2-par650097-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205100-anti-human-par2-par650097-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205101-anti-human-mpl-tpor-cd110-ta136-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205102-anti-human-mpl-tpor-cd110-ta136-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205103-anti-human-mpl-tpor-cd110-ta136-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205104-anti-human-scn9a-nav1-7-duke-anti-nav1-7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205105-anti-human-scn9a-nav1-7-duke-anti-nav1-7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205106-anti-human-scn9a-nav1-7-duke-anti-nav1-7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205107-anti-human-cd163-or2805-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205108-anti-human-cd163-or2805-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205109-anti-human-cd163-or2805-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205110-anti-human-folr1-fra-dompe-patent-anti-folr1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205111-anti-human-folr1-fra-dompe-patent-anti-folr1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205112-anti-human-folr1-fra-dompe-patent-anti-folr1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205113-anti-human-ptprc-cd45-apamistamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205114-anti-human-ptprc-cd45-apamistamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205115-anti-human-ptprc-cd45-apamistamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205116-anti-human-cd47-ligufalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205117-anti-human-cd47-ligufalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205118-anti-human-cd47-ligufalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205119-anti-human-golm1-cureab-patent-anti-gp73-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205120-anti-human-golm1-cureab-patent-anti-gp73-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205121-anti-human-golm1-cureab-patent-anti-gp73-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205122-anti-human-tnfrsf5-cd40-emory-u-anti-cd40-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205123-anti-human-tnfrsf5-cd40-emory-u-anti-cd40-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205124-anti-human-tnfrsf5-cd40-emory-u-anti-cd40-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205125-anti-human-rgmc-hfe2-disc-0974-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205126-anti-human-rgmc-hfe2-disc-0974-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205127-anti-human-rgmc-hfe2-disc-0974-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205128-anti-human-complement-factor-d-lampalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205129-anti-human-complement-factor-d-lampalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205130-anti-human-complement-factor-d-lampalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205131-anti-human-kir2dl1-cd158a-innate-patent-anti-kir2dl-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205132-anti-human-kir2dl1-cd158a-innate-patent-anti-kir2dl-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205133-anti-human-kir2dl1-cd158a-innate-patent-anti-kir2dl-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205134-anti-human-cd28-fr104-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205135-anti-human-cd28-fr104-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205136-anti-human-cd28-fr104-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205137-anti-human-cd20-divozilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205138-anti-human-cd20-divozilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205139-anti-human-cd20-divozilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205140-anti-human-scn11a-nav1-9-wuhan-u-patent-anti-nav1-9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205141-anti-human-scn11a-nav1-9-wuhan-u-patent-anti-nav1-9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205142-anti-human-scn11a-nav1-9-wuhan-u-patent-anti-nav1-9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205143-anti-human-il-12b-ebdarokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205144-anti-human-il-12b-ebdarokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205145-anti-human-il-12b-ebdarokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205146-anti-human-cd34-itri-patent-anti-cd34-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205147-anti-human-cd34-itri-patent-anti-cd34-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205148-anti-human-cd34-itri-patent-anti-cd34-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205149-anti-human-vegf-domantis-patent-anti-vegf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205150-anti-human-vegf-domantis-patent-anti-vegf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205151-anti-human-vegf-domantis-patent-anti-vegf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205152-anti-human-il-5-depemokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205153-anti-human-il-5-depemokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205154-anti-human-il-5-depemokimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205155-anti-human-clec4c-lfb-patent-anti-bdca-2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205156-anti-human-clec4c-lfb-patent-anti-bdca-2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205157-anti-human-clec4c-lfb-patent-anti-bdca-2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205158-anti-human-ceacam1-cd66a-chaim-sheba-med-cntr-patent-anti-ceacam1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205159-anti-human-ceacam1-cd66a-chaim-sheba-med-cntr-patent-anti-ceacam1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205160-anti-human-ceacam1-cd66a-chaim-sheba-med-cntr-patent-anti-ceacam1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205161-anti-human-il-13ra1-cd213a1-mk-6105-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205162-anti-human-il-13ra1-cd213a1-mk-6105-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205163-anti-human-il-13ra1-cd213a1-mk-6105-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205164-anti-human-ctla-4-cd152-zalifrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205165-anti-human-ctla-4-cd152-zalifrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205166-anti-human-ctla-4-cd152-zalifrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205167-anti-human-axl-ufo-enapotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205168-anti-human-axl-ufo-enapotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205169-anti-human-axl-ufo-enapotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205170-anti-human-complement-c5-lendalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205171-anti-human-complement-c5-lendalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205172-anti-human-complement-c5-lendalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205173-anti-human-erbb2-her2-cd340-coprelotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205174-anti-human-erbb2-her2-cd340-coprelotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205175-anti-human-erbb2-her2-cd340-coprelotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205176-anti-human-f9-factor-ix-emicizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205177-anti-human-f9-factor-ix-emicizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205178-anti-human-sphingosine-1-phosphate-expression-dd-patent-anti-sip-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205179-anti-human-sphingosine-1-phosphate-expression-dd-patent-anti-sip-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205180-anti-human-sphingosine-1-phosphate-expression-dd-patent-anti-sip-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205181-anti-human-serpine1-sanofi-patent-anti-pai-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205182-anti-human-serpine1-sanofi-patent-anti-pai-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205183-anti-human-serpine1-sanofi-patent-anti-pai-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205184-anti-human-integrin-a4b7-etrolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205185-anti-human-integrin-a4b7-etrolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205186-anti-human-integrin-a4b7-etrolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205187-anti-human-tmprss2-regeneron-patent-anti-tmprss2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205188-anti-human-tmprss2-regeneron-patent-anti-tmprss2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205189-anti-human-tmprss2-regeneron-patent-anti-tmprss2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205190-anti-human-trp1-tyrp1-flanvotumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205191-anti-human-trp1-tyrp1-flanvotumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205192-anti-human-trp1-tyrp1-flanvotumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205193-anti-human-epcam-trop1-cd326-adecatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205194-anti-human-epcam-trop1-cd326-adecatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205195-anti-human-epcam-trop1-cd326-adecatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205196-anti-human-nogo-receptor-ngr-abbott-patent-anti-ngr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205197-anti-human-nogo-receptor-ngr-abbott-patent-anti-ngr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205198-anti-human-nogo-receptor-ngr-abbott-patent-anti-ngr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205199-anti-human-cd28-lulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205200-anti-human-cd28-lulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205201-anti-human-cd28-lulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205202-anti-human-cd83-genentech-patent-anti-cd83-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205203-anti-human-cd83-genentech-patent-anti-cd83-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205204-anti-human-cd83-genentech-patent-anti-cd83-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205205-anti-human-tnfsf2-tnfa-epitomics-patent-anti-tnf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205206-anti-human-tnfsf2-tnfa-epitomics-patent-anti-tnf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205207-anti-human-tnfsf2-tnfa-epitomics-patent-anti-tnf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205208-anti-human-ctla-8-il-17a-cat-2200-biosimilar 2026-08-13T12:34:48.527Z weekly 0.9 https://gentaur.com/products/25205209-anti-human-ctla-8-il-17a-cat-2200-biosimilar 2026-08-13T12:34:48.527Z weekly 0.9 https://gentaur.com/products/25205210-anti-human-ctla-8-il-17a-cat-2200-biosimilar 2026-08-13T12:34:48.527Z weekly 0.9 https://gentaur.com/products/25205211-anti-human-csf1r-m-csfr-cd115-ly3022855-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205212-anti-human-csf1r-m-csfr-cd115-ly3022855-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205213-anti-human-csf1r-m-csfr-cd115-ly3022855-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205214-anti-human-tnfsf5-cd40l-cd154-dapirolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205215-anti-human-tnfsf5-cd40l-cd154-dapirolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205216-anti-human-tnfsf5-cd40l-cd154-dapirolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205217-anti-human-pcsk9-ebronucimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205218-anti-human-pcsk9-ebronucimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205219-anti-human-pcsk9-ebronucimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205220-anti-human-ceacam5-cea-cd66e-cergutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205221-anti-human-ceacam5-cea-cd66e-cergutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205222-anti-human-ceacam5-cea-cd66e-cergutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205223-anti-human-csf2-gm-csf-gimsilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205224-anti-human-csf2-gm-csf-gimsilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205225-anti-human-csf2-gm-csf-gimsilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205226-anti-human-igf1r-cd221-dalotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205227-anti-human-igf1r-cd221-dalotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205228-anti-human-igf1r-cd221-dalotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205229-anti-human-cd3-visilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205230-anti-human-cd3-visilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205231-anti-human-cd3-visilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205232-anti-human-ctla-8-il-17a-ixekizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205233-anti-human-ctla-8-il-17a-ixekizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205234-anti-human-ctla-8-il-17a-ixekizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205235-anti-human-ctla-8-il-17a-netakimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205236-anti-human-ctla-8-il-17a-netakimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205237-anti-human-ctla-8-il-17a-netakimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205238-anti-human-cdh3-p-cadherin-pf-03732010-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205239-anti-human-cdh3-p-cadherin-pf-03732010-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205240-anti-human-cdh3-p-cadherin-pf-03732010-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205241-anti-human-ceacam6-cd66c-tinurilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205242-anti-human-ceacam6-cd66c-tinurilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205243-anti-human-ceacam6-cd66c-tinurilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205244-anti-human-pcsk9-evolocumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205245-anti-human-pcsk9-evolocumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205246-anti-human-pcsk9-evolocumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205247-anti-human-muc17-forerunner-patent-anti-muc-17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205248-anti-human-muc17-forerunner-patent-anti-muc-17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205249-anti-human-muc17-forerunner-patent-anti-muc-17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205250-anti-human-complement-c5-ravulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205251-anti-human-complement-c5-ravulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205252-anti-human-complement-c5-ravulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205253-anti-human-cd38-felzartamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205254-anti-human-cd38-felzartamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205255-anti-human-cd38-felzartamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205256-anti-human-cd59-quark-patent-anti-cd59-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205257-anti-human-cd59-quark-patent-anti-cd59-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205258-anti-human-cd59-quark-patent-anti-cd59-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205259-anti-human-cxcl8-il-8-genentech-patent-anti-il-8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205260-anti-human-cxcl8-il-8-genentech-patent-anti-il-8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205261-anti-human-cxcl8-il-8-genentech-patent-anti-il-8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205262-anti-human-ctla-4-cd152-nurulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205263-anti-human-ctla-4-cd152-nurulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205264-anti-human-ctla-4-cd152-nurulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205265-anti-human-cd9-genentech-patent-anti-cd9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205266-anti-human-cd9-genentech-patent-anti-cd9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205267-anti-human-cd9-genentech-patent-anti-cd9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205268-anti-human-tigit-domvanalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205269-anti-human-tigit-domvanalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205270-anti-human-tigit-domvanalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205271-anti-human-cd47-urabrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205272-anti-human-cd47-urabrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205273-anti-human-cd47-urabrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205274-anti-human-erbb1-egfr-her1-laprituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205275-anti-human-erbb1-egfr-her1-laprituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205276-anti-human-erbb1-egfr-her1-laprituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205277-anti-human-amyloid-beta-donanemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205278-anti-human-amyloid-beta-donanemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205279-anti-human-amyloid-beta-donanemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205280-anti-human-ctla-4-cd152-tremelimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205281-anti-human-ctla-4-cd152-tremelimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205282-anti-human-ctla-4-cd152-tremelimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205283-anti-human-cd47-letaplimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205284-anti-human-cd47-letaplimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205285-anti-human-cd47-letaplimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205286-anti-human-cxcl12-sdf1a-genentech-anti-cxcl12-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205287-anti-human-cxcl12-sdf1a-genentech-anti-cxcl12-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205288-anti-human-cxcl12-sdf1a-genentech-anti-cxcl12-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205289-anti-human-il-6-ifnb2-elsilimomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205290-anti-human-il-6-ifnb2-elsilimomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205291-anti-human-il-6-ifnb2-elsilimomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205292-anti-human-erbb1-egfr-her1-duke-d2c7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205293-anti-human-erbb1-egfr-her1-duke-d2c7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205294-anti-human-erbb1-egfr-her1-duke-d2c7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205295-anti-human-pcsk9-frovocimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205296-anti-human-pcsk9-frovocimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205297-anti-human-pcsk9-frovocimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205298-anti-human-erbb1-egfr-her1-shanghai-cancer-inst-patent-anti-egfrviii-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205299-anti-human-erbb1-egfr-her1-shanghai-cancer-inst-patent-anti-egfrviii-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205300-anti-human-erbb1-egfr-her1-shanghai-cancer-inst-patent-anti-egfrviii-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205301-anti-human-ctla-8-il-17a-perakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205302-anti-human-ctla-8-il-17a-perakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205303-anti-human-ctla-8-il-17a-perakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205304-anti-human-csf2-gm-csf-lenzilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205305-anti-human-csf2-gm-csf-lenzilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205306-anti-human-csf2-gm-csf-lenzilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205307-anti-human-tem7r-plxdc2-fox-chase-patent-anti-tem7r-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205308-anti-human-tem7r-plxdc2-fox-chase-patent-anti-tem7r-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205309-anti-human-tem7r-plxdc2-fox-chase-patent-anti-tem7r-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205310-anti-human-pdcd1-pd-1-cd279-finotonlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205311-anti-human-pdcd1-pd-1-cd279-finotonlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205312-anti-human-pdcd1-pd-1-cd279-finotonlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205313-anti-human-tyro3-elb031-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205314-anti-human-tyro3-elb031-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205315-anti-human-tyro3-elb031-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205316-anti-human-cd3e-foralumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205317-anti-human-cd3e-foralumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205318-anti-human-cd3e-foralumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205319-anti-human-tnfrsf5-cd40-giloralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205320-anti-human-tnfrsf5-cd40-giloralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205321-anti-human-tnfrsf5-cd40-giloralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205322-anti-human-ceacam5-cea-cd66e-tusamitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205323-anti-human-ceacam5-cea-cd66e-tusamitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205324-anti-human-ceacam5-cea-cd66e-tusamitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205325-anti-human-clathrin-heavy-chain-chc-academia-sinica-patent-anti-clathrin-heavy-chain-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205326-anti-human-clathrin-heavy-chain-chc-academia-sinica-patent-anti-clathrin-heavy-chain-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205327-anti-human-clathrin-heavy-chain-chc-academia-sinica-patent-anti-clathrin-heavy-chain-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205328-anti-human-erbb1-egfr-her1-imgatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205329-anti-human-erbb1-egfr-her1-imgatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205330-anti-human-erbb1-egfr-her1-imgatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205331-anti-human-complement-c5ar1-g2-patent-anti-c5ar-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205332-anti-human-complement-c5ar1-g2-patent-anti-c5ar-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205333-anti-human-complement-c5ar1-g2-patent-anti-c5ar-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205334-anti-human-vegfr2-kdr-cd309-imclone-6-64-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205335-anti-human-vegfr2-kdr-cd309-imclone-6-64-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205336-anti-human-vegfr2-kdr-cd309-imclone-6-64-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205337-anti-human-complement-factor-b-genentech-patent-anti-factor-b-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205338-anti-human-complement-factor-b-genentech-patent-anti-factor-b-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205339-anti-human-complement-factor-b-genentech-patent-anti-factor-b-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205340-anti-human-btla-cd272-icatolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205341-anti-human-btla-cd272-icatolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205342-anti-human-btla-cd272-icatolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205343-anti-human-muc1-gatipotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205344-anti-human-muc1-gatipotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205345-anti-human-muc1-gatipotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205346-anti-human-csf2-gm-csf-namilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205347-anti-human-csf2-gm-csf-namilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205348-anti-human-csf2-gm-csf-namilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205349-anti-human-ddr1-cd167a-imperial-college-anti-ddr1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205350-anti-human-ddr1-cd167a-imperial-college-anti-ddr1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205351-anti-human-ddr1-cd167a-imperial-college-anti-ddr1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205352-anti-human-tnfsf2-tnfa-golimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205353-anti-human-tnfsf2-tnfa-golimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205354-anti-human-tnfsf2-tnfa-golimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205355-anti-human-erbb2-her2-cd340-margetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205356-anti-human-erbb2-her2-cd340-margetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205357-anti-human-erbb2-her2-cd340-margetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205358-anti-human-notch3-genentech-patent-anti-notch3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205359-anti-human-notch3-genentech-patent-anti-notch3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205360-anti-human-notch3-genentech-patent-anti-notch3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205361-anti-human-ifng-fontolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205362-anti-human-ifng-fontolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205363-anti-human-ifng-fontolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205364-anti-human-ctla-8-il-17a-ucb-patent-anti-il-17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205365-anti-human-ctla-8-il-17a-ucb-patent-anti-il-17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205366-anti-human-ctla-8-il-17a-ucb-patent-anti-il-17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205367-anti-human-tspan8-inserm-patent-anti-co-029-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205368-anti-human-tspan8-inserm-patent-anti-co-029-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205369-anti-human-tspan8-inserm-patent-anti-co-029-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205370-anti-human-b7-h1-pd-l1-cd274-adebrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205371-anti-human-b7-h1-pd-l1-cd274-adebrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205372-anti-human-b7-h1-pd-l1-cd274-adebrelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205373-anti-human-cxcl8-il-8-abx-il8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205374-anti-human-cxcl8-il-8-abx-il8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205375-anti-human-cxcl8-il-8-abx-il8-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205376-anti-human-erbb1-egfr-her1-7a7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205377-anti-human-erbb1-egfr-her1-7a7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205378-anti-human-erbb1-egfr-her1-7a7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205379-anti-human-ctla-8-il-17a-vunakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205380-anti-human-ctla-8-il-17a-vunakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205381-anti-human-ctla-8-il-17a-vunakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205382-anti-human-csf1r-m-csfr-cd115-emactuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205383-anti-human-csf1r-m-csfr-cd115-emactuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205384-anti-human-csf1r-m-csfr-cd115-emactuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205385-anti-human-erbb1-egfr-her1-chinese-mil-med-sci-patent-anti-egfr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205386-anti-human-erbb1-egfr-her1-chinese-mil-med-sci-patent-anti-egfr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205387-anti-human-erbb1-egfr-her1-chinese-mil-med-sci-patent-anti-egfr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205388-anti-human-erbb2-her2-cd340-timigutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205389-anti-human-erbb2-her2-cd340-timigutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205390-anti-human-erbb2-her2-cd340-timigutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205391-anti-human-cxcr4-cd184-dana-farber-patent-anti-cxcr4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205392-anti-human-cxcr4-cd184-dana-farber-patent-anti-cxcr4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205393-anti-human-cxcr4-cd184-dana-farber-patent-anti-cxcr4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205394-anti-human-clec4c-biib059-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205395-anti-human-clec4c-biib059-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205396-anti-human-clec4c-biib059-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205397-anti-human-igf1r-cd221-immunomedics-patent-anti-igf-1r-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205398-anti-human-igf1r-cd221-immunomedics-patent-anti-igf-1r-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205399-anti-human-igf1r-cd221-immunomedics-patent-anti-igf-1r-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205400-anti-human-pdcd1-pd-1-cd279-geptanolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205401-anti-human-pdcd1-pd-1-cd279-geptanolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205402-anti-human-pdcd1-pd-1-cd279-geptanolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205403-anti-human-kaag1-adct-901-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205404-anti-human-kaag1-adct-901-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205405-anti-human-amyloid-beta-georgetown-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205406-anti-human-amyloid-beta-georgetown-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205407-anti-human-amyloid-beta-georgetown-u-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205408-anti-human-cdh17-cadherin-17-pta001-a4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205409-anti-human-cdh17-cadherin-17-pta001-a4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205410-anti-human-cdh17-cadherin-17-pta001-a4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205411-anti-human-epha3-ifabotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205412-anti-human-epha3-ifabotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205413-anti-human-epha3-ifabotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205414-anti-human-erbb1-egfr-her1-matuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205415-anti-human-erbb1-egfr-her1-matuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205416-anti-human-erbb1-egfr-her1-matuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205417-anti-human-pdcd1-pd-1-cd279-dostarlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205418-anti-human-pdcd1-pd-1-cd279-dostarlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205419-anti-human-pdcd1-pd-1-cd279-dostarlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205420-anti-human-cdh1-e-cadherin-cd324-stem-centrx-patent-anti-cadherin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205421-anti-human-cdh1-e-cadherin-cd324-stem-centrx-patent-anti-cadherin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205422-anti-human-cdh1-e-cadherin-cd324-stem-centrx-patent-anti-cadherin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205423-anti-human-cd19-immunomedics-ha19-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205424-anti-human-cd19-immunomedics-ha19-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205425-anti-human-cd19-immunomedics-ha19-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205426-anti-human-cxcl10-ip-10-ni-0801-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205427-anti-human-cxcl10-ip-10-ni-0801-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205428-anti-human-cxcl10-ip-10-ni-0801-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205429-anti-human-f11-factor-xi-abelacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205430-anti-human-f11-factor-xi-abelacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205431-anti-human-f11-factor-xi-abelacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205432-anti-human-cd79b-iladatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205433-anti-human-cd79b-iladatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205434-anti-human-cd79b-iladatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205435-anti-human-fzd-vantictumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205436-anti-human-fzd-vantictumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205437-anti-human-fzd-vantictumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205438-anti-human-dll4-enoticumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205439-anti-human-dll4-enoticumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205440-anti-human-dll4-enoticumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205441-anti-human-erbb3-her3-barecetamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205442-anti-human-erbb3-her3-barecetamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205443-anti-human-erbb3-her3-barecetamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205444-anti-human-integrin-a4b7-vedolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205445-anti-human-integrin-a4b7-vedolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205446-anti-human-integrin-a4b7-vedolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205447-anti-human-aa2ar-adenosine-a2ar-3f6-9g5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205448-anti-human-aa2ar-adenosine-a2ar-3f6-9g5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205449-anti-human-aa2ar-adenosine-a2ar-3f6-9g5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205450-anti-human-erbb1-egfr-her1-demupitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205451-anti-human-erbb1-egfr-her1-demupitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205452-anti-human-erbb1-egfr-her1-demupitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205453-anti-human-gpnmb-glembatumumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205454-anti-human-cd52-gatralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205455-anti-human-cd52-gatralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205456-anti-human-cd52-gatralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205457-anti-human-dll4-smart-targeting-patent-anti-dll4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205458-anti-human-dll4-smart-targeting-patent-anti-dll4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205459-anti-human-dll4-smart-targeting-patent-anti-dll4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205460-anti-human-erbb2-her2-cd340-trastuzumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205461-anti-human-fcer2-cd23-lumiliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205462-anti-human-fcer2-cd23-lumiliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205463-anti-human-fcer2-cd23-lumiliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205464-anti-human-siglec-2-cd22-pinatuzumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205465-anti-human-steap1-vandortuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205466-anti-human-steap1-vandortuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205467-anti-human-steap1-vandortuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205468-anti-human-erbb3-her3-lumretuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205469-anti-human-erbb3-her3-lumretuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205470-anti-human-erbb3-her3-lumretuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205471-anti-human-icam3-cd50-forerunner-patent-anti-icam-3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205472-anti-human-icam3-cd50-forerunner-patent-anti-icam-3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205473-anti-human-icam3-cd50-forerunner-patent-anti-icam-3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205474-anti-human-cldn6-64a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205475-anti-human-cldn6-64a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205476-anti-human-cldn6-64a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205477-anti-human-tnfrsf4-ox40-cd134-vonlerizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205478-anti-human-tnfrsf4-ox40-cd134-vonlerizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205479-anti-human-tnfrsf4-ox40-cd134-vonlerizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205480-anti-human-erbb3-her3-patritumab-deruxtecan-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205481-anti-human-siglec-2-cd22-inotuzumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205482-anti-human-il-1b-gevokizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205483-anti-human-il-1b-gevokizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205484-anti-human-il-1b-gevokizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205485-anti-human-folh1-psma-pelgifatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205486-anti-human-folh1-psma-pelgifatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205487-anti-human-folh1-psma-pelgifatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205488-anti-human-axl-ufo-tilvestamab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205489-anti-human-axl-ufo-tilvestamab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205490-anti-human-erbb2-her2-cd340-hersintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205491-anti-human-erbb2-her2-cd340-hersintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205492-anti-human-erbb2-her2-cd340-hersintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205493-anti-human-pdcd1-pd-1-cd279-iparomlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205494-anti-human-pdcd1-pd-1-cd279-iparomlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205495-anti-human-pdcd1-pd-1-cd279-iparomlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205496-anti-human-vegfc-vgx100-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205497-anti-human-vegfc-vgx100-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205498-anti-human-vegfc-vgx100-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205499-anti-human-ncam1-cd56-lorvotuzumab-mertansine-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205500-anti-human-fgfr1-cd331-lilly-patent-anti-fgfr-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205501-anti-human-fgfr1-cd331-lilly-patent-anti-fgfr-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205502-anti-human-fgfr1-cd331-lilly-patent-anti-fgfr-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205503-anti-human-tigit-vibostolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205504-anti-human-tigit-vibostolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205505-anti-human-tigit-vibostolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205506-anti-human-tnfsf2-tnfa-cmab008-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205507-anti-human-tnfsf2-tnfa-cmab008-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205508-anti-human-tnfsf2-tnfa-cmab008-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205509-anti-human-erbb1-egfr-her1-depatuxizumab-mmaf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205510-anti-human-tnfrsf4-ox40-cd134-ivuxolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205511-anti-human-tnfrsf4-ox40-cd134-ivuxolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205512-anti-human-tnfrsf4-ox40-cd134-ivuxolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205513-anti-human-tm4sf1-beth-israel-patent-anti-tm4sf1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205514-anti-human-tm4sf1-beth-israel-patent-anti-tm4sf1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205515-anti-human-tm4sf1-beth-israel-patent-anti-tm4sf1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205516-anti-human-tgfb1-fresolimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205517-anti-human-tgfb1-fresolimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205518-anti-human-tgfb1-fresolimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205519-anti-human-tf-factor-iii-tissue-factor-cd142-tisotumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205520-anti-human-mu5ac-ensituximab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205521-anti-human-erbb1-egfr-her1-necitumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205522-anti-human-erbb1-egfr-her1-necitumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205523-anti-human-erbb1-egfr-her1-necitumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205524-anti-human-alcam-cd166-praluzatamab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205525-anti-human-muc1-clivatuzumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205526-anti-human-tnfrsf18-gitr-cd357-korea-natl-cancer-ctr-patent-anti-gitr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205527-anti-human-tnfrsf18-gitr-cd357-korea-natl-cancer-ctr-patent-anti-gitr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205528-anti-human-tnfrsf18-gitr-cd357-korea-natl-cancer-ctr-patent-anti-gitr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205529-anti-human-fcrh5-irta2-cd307e-dfrf4539a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205530-anti-human-fcrh5-irta2-cd307e-dfrf4539a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205531-anti-human-fcrh5-irta2-cd307e-dfrf4539a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205532-anti-human-tnfrsf5-cd40-mitazalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205533-anti-human-tnfrsf5-cd40-mitazalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205534-anti-human-tnfrsf5-cd40-mitazalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205535-anti-human-caprin1-toray-patent-anti-caprin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205536-anti-human-caprin1-toray-patent-anti-caprin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205537-anti-human-caprin1-toray-patent-anti-caprin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205538-anti-human-cd79b-polatuzumab-vedotin-piiq-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205539-anti-human-gucy2c-indusatumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205540-anti-human-cd79b-iladatuzumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205541-anti-human-cd79b-iladatuzumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205542-anti-human-vegf-ranibizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205543-anti-human-vegf-ranibizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205544-anti-human-vegf-ranibizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205545-anti-human-ceacam5-cea-cd66e-immunomedics-patent-anti-ceacam5-class-iii-biosimilar-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205546-anti-human-ceacam5-cea-cd66e-immunomedics-patent-anti-ceacam5-class-iii-biosimilar-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205547-anti-human-ceacam5-cea-cd66e-immunomedics-patent-anti-ceacam5-class-iii-biosimilar-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205548-anti-human-erbb1-egfr-her1-zalutumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205549-anti-human-erbb1-egfr-her1-zalutumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205550-anti-human-erbb1-egfr-her1-zalutumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205551-anti-human-ror2-ozuriftamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205552-anti-human-ror2-ozuriftamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205553-anti-human-ror2-ozuriftamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205554-anti-human-alcam-cd166-praluzatamab-ravtansine-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205555-anti-human-trop2-sacituzumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205556-anti-human-cd36-ona-thera-patent-anti-cd36-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205557-anti-human-cd36-ona-thera-patent-anti-cd36-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205558-anti-human-cd36-ona-thera-patent-anti-cd36-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205559-anti-human-folr1-fra-farletuzumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205560-anti-human-cxcr4-cd184-ulocuplumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205561-anti-human-ctla-4-cd152-antitope-patent-anti-ctla4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205562-anti-human-ctla-4-cd152-antitope-patent-anti-ctla4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205563-anti-human-ctla-4-cd152-antitope-patent-anti-ctla4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205564-anti-human-ncam1-cd56-lorvotuzumab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205565-anti-human-cldn6-ds-9606a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205566-anti-human-cldn6-ds-9606a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205567-anti-human-cldn6-ds-9606a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205568-anti-human-tfr-jr-141-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205569-anti-human-tfr-jr-141-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205570-anti-human-tfr-jr-141-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205571-anti-human-folh1-psma-rosopatamab-mmae-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205572-anti-human-amyloid-beta-u-zurich-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205573-anti-human-amyloid-beta-u-zurich-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205574-anti-human-amyloid-beta-u-zurich-patent-anti-amyloid-beta-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205578-anti-human-nectin-4-enfortumab-vedotin-ejfv-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205579-anti-human-nectin-4-enfortumab-vedotin-ejfv-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205580-anti-human-erbb2-her2-cd340-gancotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205581-anti-human-erbb2-her2-cd340-gancotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205582-anti-human-erbb2-her2-cd340-gancotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205583-anti-human-erbb1-egfr-her1-serclutamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205584-anti-human-erbb1-egfr-her1-serclutamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205585-anti-human-erbb1-egfr-her1-serclutamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205586-anti-human-ceacam5-cea-cd66e-tusamitamab-ravtansine-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205587-anti-human-canag-cantuzumab-ravtansine-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205588-anti-human-tnfsf7-cd27l-cd70-vorsetuzumab-mafodotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205589-anti-human-siglec-3-cd33-gemtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205590-anti-human-siglec-3-cd33-gemtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205591-anti-human-siglec-3-cd33-gemtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205592-anti-human-tpbg-asn004-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205593-anti-human-tpbg-asn004-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205594-anti-human-tpbg-asn004-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205595-anti-human-ang2-vegfa-faricimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205596-anti-human-ang2-vegfa-faricimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205597-anti-human-mrc2-cd280-quark-patent-anti-endo180-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205598-anti-human-mrc2-cd280-quark-patent-anti-endo180-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205599-anti-human-mrc2-cd280-quark-patent-anti-endo180-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205600-anti-human-slitrk6-sirtratumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205601-anti-human-slitrk6-sirtratumab-vedotin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205602-anti-human-fibronectin-radretumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205603-anti-human-fibronectin-radretumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205604-anti-human-fibronectin-radretumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205605-anti-human-tgfb1-genzyme-patent-anti-tgf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25205606-anti-human-tgfb1-genzyme-patent-anti-tgf-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205607-anti-human-tgfb1-genzyme-patent-anti-tgf-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205608-anti-human-dll3-rovalpituzumab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205609-anti-human-glp1r-centocor-patent-anti-glp-1r-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205610-anti-human-glp1r-centocor-patent-anti-glp-1r-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205611-anti-human-glp1r-centocor-patent-anti-glp-1r-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205612-anti-human-cd3-fcrl5-cevostamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205613-anti-human-amyloid-beta-bapineuzumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205614-anti-human-amyloid-beta-bapineuzumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205615-anti-human-amyloid-beta-bapineuzumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205616-anti-human-canag-cantuzumab-mertansine-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205617-anti-human-cd137-her2-cinrebafusp-alfa-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205618-anti-human-tnfsf14-light-cd258-sar252067-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205619-anti-human-tnfsf14-light-cd258-sar252067-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205620-anti-human-tnfsf14-light-cd258-sar252067-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205621-anti-human-tnfsf2-tnfa-esba-105-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205622-anti-human-tnfsf2-tnfa-esba-105-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205623-anti-human-tnfsf2-tnfa-esba-105-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205624-anti-human-cdcp1-cd318-38-e11-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205625-anti-human-cdcp1-cd318-38-e11-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205626-anti-human-cdcp1-cd318-38-e11-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205627-anti-human-slc7a11-agilvax-patent-anti-slc7a11-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205628-anti-human-slc7a11-agilvax-patent-anti-slc7a11-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205629-anti-human-slc7a11-agilvax-patent-anti-slc7a11-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205630-anti-human-il-3ra-cd123-talacotuzumab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205631-anti-human-il-3ra-cd123-talacotuzumab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205632-anti-human-napi2b-slc34a2-lifastuzumab-vedotin-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205633-anti-rabies-virus-gp-foravirumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205634-anti-rabies-virus-gp-foravirumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205635-anti-rabies-virus-gp-foravirumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205636-anti-human-mesothelin-anetumab-ravtansine-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205637-anti-human-tau-zagotenemab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205638-anti-human-tau-zagotenemab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205639-anti-human-tau-zagotenemab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205640-anti-human-muc16-sofituzumab-vedotin-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205641-anti-human-cd98-ign523-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205642-anti-human-cd98-ign523-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205643-anti-human-cd98-ign523-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205644-anti-human-pvr-cd155-ntx1088-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205645-anti-human-pvr-cd155-ntx1088-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205646-anti-human-pvr-cd155-ntx1088-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205647-anti-rabies-virus-gp-rafivirumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205648-anti-rabies-virus-gp-rafivirumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205649-anti-rabies-virus-gp-rafivirumab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205650-anti-human-gprc5d-cd3-talquetamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205651-anti-human-gprc5d-cd3-talquetamab-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205652-anti-human-ca9-caix-girentuximab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205653-anti-human-cldn6-ab3-7-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205654-anti-human-cldn6-ab3-7-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205655-anti-human-cldn6-ab3-7-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205656-anti-human-amhr2-murlentamab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205657-anti-human-enpp3-cd203c-ags-16c3f-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205658-anti-human-enpp3-cd203c-ags-16c3f-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205659-anti-human-enpp3-cd203c-ags-16c3f-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205660-anti-human-mage-a4-imc-c103c-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205661-anti-human-mage-a4-imc-c103c-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205662-anti-human-mage-a4-imc-c103c-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205663-anti-human-trem2-py314-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205664-anti-human-trem2-py314-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205665-anti-human-trem2-py314-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205666-anti-human-erbb3-her3-patritumab-mmae-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205667-anti-human-mspr-ron-cd136-h5b14-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9 https://gentaur.com/products/25205668-anti-human-mspr-ron-cd136-h5b14-biosimilar 2026-06-03T16:46:27.205Z weekly 0.9